Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Alzheimer's beta-amyloid vasoactivity: identification of a novel beta-amyloid conformational intermediate.
[hereditary cerebral hemorrhage with amyloidosis]
The
beta
-amyloid
(
A
beta
)
peptide
has
previously
been
shown
to
enhance
phenylephrine
or
endothelin-
1
induced
constriction
of
aortic
rings
in
vitro
.
The
characteristics
of
A
beta
vasoactivity
(
dose
,
fragment
length
,
timing
)
suggest
that
the
mechanism
is
distinct
from
A
beta
cytotoxicity
.
To
identify
which
properties
of
A
beta
determine
its
biological
activity
on
vessels
,
we
investigated
a
number
of
A
beta
analogues
and
fragments
,
individually
and
in
combination
,
including
those
that
are
known
to
be
associated
with
Alzheimer
's
disease
(
A
beta
(
1
-
42
)
)
and
hereditary
cerebral
hemorrhage
with
amyloidosis
--
Dutch
type
(
A
beta
(
22
Q
)
(
1
-
40
)
)
.
The
vasoactivity
appears
to
be
related
to
the
conformation
adopted
by
the
peptide
in
solution
.
The
beta
-pleated
sheet
rich
A
beta
(
1
-
42
)
and
A
beta
(
22
Q
)
(
1
-
40
)
were
each
less
vasoactive
than
the
mainly
random
coil
wild
type
A
beta
(
1
-
40
)
.
However
,
the
most
vasoactive
A
beta
peptides
were
combinations
which
contain
mixtures
of
random
coil
and
beta
-sheet
structure
.
The
finding
that
peptides
containing
low
or
high
levels
of
beta
-pleated
conformation
are
less
vasoactive
than
those
containing
intermediate
amounts
of
this
structural
motif
allows
us
to
propose
the
existence
of
a
transitional
form
between
random
coil
and
beta
-pleated
that
is
the
vasoactive
species
of
A
beta
.
This
is
the
first
time
that
A
beta
conformational
intermediates
have
been
identified
and
a
biological
activity
associated
with
them
.
Diseases
Validation
Diseases presenting
"high levels"
symptom
22q11.2 deletion syndrome
adrenal incidentaloma
allergic bronchopulmonary aspergillosis
alpha-thalassemia
aromatase deficiency
cadasil
canavan disease
classical phenylketonuria
congenital adrenal hyperplasia
congenital toxoplasmosis
cutaneous mastocytosis
cystinuria
dentin dysplasia
dentinogenesis imperfecta
dracunculiasis
dystrophic epidermolysis bullosa
erythropoietic protoporphyria
gm1 gangliosidosis
hereditary cerebral hemorrhage with amyloidosis
holt-oram syndrome
homocystinuria without methylmalonic aciduria
kabuki syndrome
kallmann syndrome
liposarcoma
papillon-lefèvre syndrome
phenylketonuria
primary effusion lymphoma
primary hyperoxaluria type 1
scrub typhus
severe combined immunodeficiency
systemic capillary leak syndrome
triple a syndrome
von hippel-lindau disease
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom